Results 1 to 10 of about 83,999 (309)
Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning [PDF]
Nature Communications, 2020 Diabetic eye disease is a cause of preventable blindness and accurate and timely referral of patients with diabetic macular edema is important to start treatment.
Avinash V. Varadarajan +17 more
doaj +3 more sources
Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema
Therapeutic Advances in Ophthalmology, 2020 Diabetic retinopathy is one of the major microvascular complications of diabetes mellitus. The most common causes of vision loss in diabetic retinopathy are diabetic macular edema and proliferative diabetic retinopathy.
Ashish Markan +5 more
doaj +2 more sources
Indian Journal of Ophthalmology, 2006 Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients.
Vedantham Vasumathy, Kim Ramasamy
doaj +2 more sources
Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema [PDF]
, 2011 Introduction: To evaluate the effect of alpha-lipoic acid (ALA) on the occurrence of diabetic macular edema. Methods: Randomized, double-blind, placebo-controlled, multicenter, multinational study. Patients were randomized to the treatment group with 600
Anselm Kampik +5 more
core +3 more sources
Predictive impact of serous retinal detachment in refractory diabetic macular edema [PDF]
BMC OphthalmologyBackground Anti-vascular endothelial growth factor (VEGF) drugs are the first-line treatment option for DME management. However, part of DME was refractory to anti-VEGF medicine.
Zhuo-hua Zhou +3 more
doaj +2 more sources
Current Treatments for Diabetic Macular Edema
International Journal of Molecular Sciences, 2023 Diabetic retinopathy is a major retinal disorder and a leading cause of blindness. Diabetic macular edema (DME) is an ocular complication in patients with diabetes, and it can impair vision significantly.
T. Tatsumi
semanticscholar +1 more source
Pharmaceutics, 2023 Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative diseases; including wet age-related macular degeneration (w-AMD) and diabetic macular edema (DME)
L. Ferro Desideri +3 more
semanticscholar +1 more source
The Role of Müller Cells in Diabetic Macular Edema
Investigative Ophthalmology and Visual Science, 2023 Diabetic macular edema (DME) is a common complication of diabetic retinopathy and is the leading cause of vision loss in diabetic patients. Various factors, such as metabolic disorders and inflammation caused by hyperglycemia, are involved in the ...
Dongwei Lai +3 more
semanticscholar +1 more source
ASSOCIATION BETWEEN THE DEGREE OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
Jurnal Kedokteran Diponegoro, 2022 INTRODUCTION: WHO estimates more than 150 million diabetes patients worldwide. One of the complications of diabetes is diabetic retinopathy which is recognized as the leading cause of blindness in the working-age population and the cause of 12% of new ...
Andhika Guna Dharma +6 more
doaj +1 more source
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Cells, 2022 Diabetic retinopathy (DR), with increasing incidence, is the major cause of vision loss and blindness worldwide in working-age adults. Diabetic macular edema (DME) remains the main cause of vision impairment in diabetic patients, with its pathogenesis ...
Jingfa Zhang +6 more
semanticscholar +1 more source